NEW GSK/ISHIB MEDICAL FELLOWSHIP AND MASTER CLINICIAN AWARDS AVAILABLE FOR ISHIB2006: The Evolving Metabolic Syndrome: Cardiovascular Risk Burdens in Ethnic Populations

June 23-26, 2006; Sheraton Atlanta Hotel; Atlanta, Georgia

April 13, 2006 – Atlanta, Georgia. ISHIB, the International Society on Hypertension in Blacks, Inc today announces the availability of two new medical education initiatives, the GlaxoSmithKline / ISHIB Medical Fellowship Program and the GlaxoSmithKline / ISHIB Master Clinicians Program. Nomination deadline is April 28 for both programs.

The GlaxoSmithKline / ISHIB Medical Fellowship Program. This award is designed to assist primary care physicians, and medical fellows and residents to participate in the ISHIB Hypertension Academy - a one day hypertension primer taking place on June 23, 2006 during ISHIB2006. Successful candidates for this program must be nominated by their residency/fellowship program director or provide service in a federally funded primary care center. Successful candidates for this award will: 1) have a demonstrated interest in being certified as a hypertension specialist; 2) provide care in an area that serves under-served populations; and 3) agree to participate in ISHIB-related cardiovascular disease research. Recipients will be required to submit an abstract/poster presentation for ISHIB2006, provide a lecture on hypertension within his or her community, and participate in a community-based screening activity sponsored by ISHIB. The award is not restricted to members of ISHIB.

Recipients of this award will receive full conference registration, coach travel, and hotel accommodations. Five fellows will be awarded through this program. For complete criteria and to nominate an individual for this award, please visit http://www.ishib.org/ISHIB2006/awards.asp

The GlaxoSmithKline / ISHIB Master Clinicians Program. ISHIB will select two recipients to enter the Master Clinicians Program. Recipients will be selected on the basis of criteria including: 1) an individual’s contributions and inspirational spirit in the work of cardiovascular disease among professional and lay communities; 2) role model, clinical skills, leadership and advocacy efforts; 3) outstanding work to develop new care models; and 4) lead role in the development of evidence-based quality improvement initiatives;

Recipients of this award will receive full conference registration, coach travel, hotel accommodations, and a $1,000 cash award. For complete criteria to apply for this award or to nominate an individual, please visit http://www.ishib.org/ISHIB2006/awards.asp

Additional award and conference information can be found at http://www.ishib.org/ISHIB2006.

GlaxoSmithKline (GSK) supports this award program with an educational grant to ISHIB.